5PSQ-056 Lot quality assurance sampling (LQAS) of a telepharmacy programme from the hospital pharmacy to the outpatient through the community pharmacy

Background and importanceThe clinical tasks of telepharmacy practice must adhere to a standardised procedure and revolve around the patient’s clinical record. Single clinical acts must be favoured. A pre-delivery validation procedure must be established before drugs reach the patients’ home. It is a...

Full description

Saved in:
Bibliographic Details
Published in:European journal of hospital pharmacy. Science and practice 2022-03, Vol.29 (Suppl 1), p.A137-A137
Main Authors: Baños-Roldán, Ú, Ramírez-Vázquez, R, Gómez-de-Rueda, F, García-González, A, Calleja-Hernández, MÁ, Guerrero-Aznar, MD
Format: Article
Language:English
Subjects:
Compliance
Conflicts of interest
Patient satisfaction
Section 5: Patient safety and quality assurance
Telemedicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and importanceThe clinical tasks of telepharmacy practice must adhere to a standardised procedure and revolve around the patient’s clinical record. Single clinical acts must be favoured. A pre-delivery validation procedure must be established before drugs reach the patients’ home. It is also essential to ensure no discrimination, confidentiality, security and traceability of the whole process (Spanish Society of Hospital Pharmacy Statement on Telepharmacy).Indicators monitoring is necessary to assess whether we are at pre-established levels of quality and to detect the existence of problematic situations.We started a new programme by which ‘Hospital-Use Medication’ is provided to outpatients through the community pharmacy, using an app to request medication by the patient and telephone communication for follow-up by the hospital pharmacist.Aim and objectivesTo monitor the quality of an informed drug delivery telepharmacy programme (CPDDTP) from the hospital pharmacy to the patient, through the community pharmacy.Material and methodsDesign: quality monitoring study using the LQAS method and a satisfaction survey.Scope: dispensations made through CPDDTP are monitored by means of a random sample from January–August 2021.Criteria evaluated: C1: validation by the pharmacist based on the clinical sheet; C2: correct dose, frequency and administration route; C3: hospital pharmacist–patient communication; C4: adherence; C5: dispensing according to protocol, single clinical act if possible; C6: time to get the medicine from request; S1: assessment of patient satisfaction by telephone survey.Starting from a 95% compliance standard, assuming a minimum threshold of 80%, an alpha error = 5% and a beta error = 20%, a sample size of 27 cases and the minimum number of protocol compliance of 23 were calculated (85%).ResultsA random sampling of 14 092 dispensations was made. 25 of 27 cases of protocol compliance were obtained (92.59%). The survey of the selected patients showed 97.4% global satisfaction. Areas to improve: a mobile app to contact patients, and diffusion of the hospital pharmacy contact e-mail and usefulness.Conclusion and relevanceThe results show the absence of a quality problem in the initial procedure studied and the patient satisfaction. The LQAS method gives us a quick way to decide if we are in a quality problem situation using a small sample. In future follow-ups, pharmaceutical care interventions should be evaluated.References and/or acknow
ISSN:2047-9956
2047-9964
DOI:10.1136/ejhpharm-2022-eahp.286